Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study.

Qin, Shukui; Cheng, Ying; Liang, Jun; Shen, Lin; Bai, Yuxian; Li, Jianfeng; Fan, Jia; Liang, Lijian; Zhang, Yaqi; Wu, Gang; Rau, Kun-Ming; Yang, Tsai-Shen; Jian, Zhixiang; Liang, Houjie; Sun, Yan

doi:10.1634/theoncologist.2014-0190

Public

Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study.

Shared by NobleBlocks on Nov 1, 2014 • 12:00 AM UTC

Authors:

Shukui Qin

Ying Cheng

Jun Liang

Abstract

BACKGROUND: The EACH study assessed the efficacy of oxaliplatin, 5-fluorouracil, and leucovorin (the FOLFOX4 regimen) compared with doxorubicin alone in terms of overall survival (OS), progression-free survival (PFS), and safety in patients with advanced hepatocellular carcinoma (HCC). We present th...

Subject

FOLFOX4 regimen

Hepatocellular carcinoma

Oxaliplatin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!